We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




3T MRI Technology Alliance to Enhance Diagnosis, Treatment, and Postoperative Evaluation of Sports Injuries

By MedImaging staff writers
Posted on 06 Aug 2008
Siemens Healthcare (Erlangen, Germany) and the Steadman Hawkins Research Foundation (Vail, CO, USA) have formed a strategic alliance that will add 3 Tesla (T) magnetic resonance imaging (MRI) technology to the Foundation and allow its clinicians and researchers better access to advanced sports medical imaging.

"Imaging has become a vital part of sports medicine for diagnosis, treatment, and postoperative evaluation,” said J. More...
Michael Egan, chief executive officer, Steadman Hawkins Research Foundation (SHRF). "Patients from all over the world are treated at Steadman Hawkins, and they return for an assessment of their progress. With this strategic alliance, we look forward to all of the new avenues in imaging research that we can explore.”

"With the strongest magnet field strength used clinically, the Magnetom Verio can be used for many applications, including neurology and functional neuroevaluation, orthopedic and cartilage assessment, breast, vascular, and cardiac imaging,” said Walter Märzendorfer, chief executive officer, Magnetic Resonance, Siemens Healthcare. "We are especially honored to join with the Steadman Hawkins Research Foundation to advance the field of orthopedic imaging and sports medicine research.”

Siemens' Magnetom Verio is a 3T MRI system with a 70-cm open bore and Total imaging matrix (Tim) technology, which combines all of these attributes into one solution. The MR system represents a new class of MRI technology that increases access to advanced diagnostic capabilities and provides high-field imaging to many patients who could not benefit from the technology before.

Once the Magnetom Verio is installed at the Foundation, Steadman Hawkins will use the data collected from it to test new software being developed specifically for orthopedic sports medicine and research being conducted in Vail. Researchers at the Foundation will then analyze the imaging data, compare it to their surgical data, and determine whether they can correlate the images with actual surgical observations.

For instance, researchers will be able to evaluate physiology of cartilage tissue and determine the health and regeneration of that tissue in a completely noninvasive way, before and after treatment. Until now, a clinician would look inside a joint, and perhaps, take a biopsy just to evaluate the results of an operation or to measure progress. If the patient happens to be an athlete, in many instances, it will be possible to determine the status of an injury without surgery and without keeping the player off the field until he or she recovers from the diagnostic procedure.

As the newest area of research at Steadman Hawkins, imaging research joins the Foundation's current departments: basic science research, clinical research, and the biomechanics research laboratory. All four departments will be integrated into the Foundation's Education and Fellowship Program.

The Magnetom Verio is expected to be installed at the Vail Valley Medical Center (VVMC) by the end of 2008. The Steadman Hawkins Clinic is partnering with SHRF to establish a new fellowship for sports medicine radiology, as well as developing specific clinical research programs for the hip, shoulder, and knee, in conjunction with Siemens.

The strategic alliance with the Steadman Hawkins Research Foundation has been signed under Siemens U.S. healthcare entity, Siemens Medical Solutions USA, Inc. (Malvern, PA, USA).

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration.

The Steadman Hawkins Research Foundation is a nonprofit charitable organization. The Foundation is dedicated to keeping individuals of all ages physically active through orthopedic research and education in the areas of arthritis, healing, rehabilitation, and injury.


Related Links:
Siemens Healthcare
Steadman Hawkins Research Foundation

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
Silver Member
ECG Management System
NEMS Web
Medical Monitor
SILENIO D
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.